Skip to main content
Premium Trial:

Request an Annual Quote

FTC Asks Varian, Agilent for More Information

NEW YORK (GenomeWeb News) – The US Federal Trade Commission has asked Varian and Agilent Technologies for additional information in connection with Agilent's proposed $1.5 billion acquisition of Varian.

Palo Alto, Calif.-based Varian said in a filing with the US Securities and Exchange Commission this week that the FTC asked both firms for more information, but it did not provide further details. The company said that the request "extends the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976 until 30 days after Agilent and Varian have substantially complied with the second request unless that period is extended voluntarily by the parties or terminated sooner by the FTC."

Agilent and Varian inked the merger agreement in late July. The firms said at the time that they expect to close the deal by the end of 2009.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.